CTI BioPharma Income Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2019 - 2020
Period Ending	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	2019 - 2020
Revenue	389.06	310.58	266.8	252.76	183.22	Upgrade
Revenue Growth (YoY)	25.27%	16.41%	5.55%	37.96%	16.95%	Upgrade
Cost of Revenue	153.19	132.02	86.34	63.71	44.52	Upgrade
Gross Profit	235.86	178.56	180.46	189.05	138.7	Upgrade
Selling, General & Admin	333.9	295.54	260.29	234.62	130.1	Upgrade
Research & Development	226.39	201.37	210.66	150.54	68.86	Upgrade
Operating Expenses	560.29	496.9	470.95	385.17	198.96	Upgrade
Operating Income	-324.42	-318.34	-290.49	-196.12	-60.26	Upgrade
Interest & Investment Income	36.19	40.08	21.98	1.83	1.26	Upgrade
Other Non Operating Income (Expenses)	0.51	-0.64	0.35	3.02	4.01	Upgrade
EBT Excluding Unusual Items	-287.73	-278.9	-268.16	-191.28	-54.99	Upgrade
Pretax Income	-287.73	-278.9	-268.16	-191.28	-54.99	Upgrade
Income Tax Expense	0.98	0.79	0.68	0.79	0.7	Upgrade
Net Income	-288.7	-279.7	-268.84	-192.07	-55.7	Upgrade
Net Income to Common	-288.7	-279.7	-268.84	-192.07	-55.7	Upgrade
Shares Outstanding (Basic)	129	119	110	104	67	Upgrade
Shares Outstanding (Diluted)	129	119	110	104	67	Upgrade
Shares Change (YoY)	8.15%	8.66%	5.22%	56.19%	86.72%	Upgrade
EPS (Basic)	-2.24	-2.34	-2.45	-1.84	-0.83	Upgrade
EPS (Diluted)	-2.24	-2.34	-2.45	-1.84	-0.83	Upgrade
Free Cash Flow	-44.45	-87.62	-186.21	-90.25	-39.18	Upgrade
Free Cash Flow Per Share	-0.34	-0.73	-1.70	-0.86	-0.59	Upgrade
Gross Margin	60.62%	57.49%	67.64%	74.79%	75.70%	Upgrade
Operating Margin	-83.39%	-102.50%	-108.88%	-77.59%	-32.89%	Upgrade
Profit Margin	-74.21%	-90.05%	-100.77%	-75.99%	-30.40%	Upgrade
Free Cash Flow Margin	-11.42%	-28.21%	-69.80%	-35.71%	-21.39%	Upgrade
EBITDA	-312.22	-306.92	-285.51	-191.63	-55.96	Upgrade
EBITDA Margin	-80.25%	-98.82%	-107.01%	-75.82%	-30.54%	Upgrade
D&A For EBITDA	12.21	11.42	4.99	4.49	4.3	Upgrade
EBIT	-324.42	-318.34	-290.49	-196.12	-60.26	Upgrade
EBIT Margin	-83.39%	-102.50%	-108.88%	-77.59%	-32.89%	Upgrade
Revenue as Reported	389.06	310.58	266.8	252.76	183.22	Upgrade
Advertising Expenses	18.3	15.8	6.9	51.9	35.3	Upgrade

Updated May 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q